Christian S. Schade has served as Executive Chairman of the board of directors since July 2022. Mr. Schade previously served as President and Chief Executive and as a member of our board of directors since June 2016, and was appointed Chairman of the board of directors in September 2020. Mr. Schade has more than 30 years of public and private pharmaceutical and biotechnology industry experience, as well as broad corporate finance expertise from his tenure in investment banking. Prior to joining Aprea, Mr. Schade was Chief Executive officer of Novira Therapeutics Inc., a privately held antiviral drug discovery company until it was acquired by Johnson & Johnson. He also served as Executive Vice President and Chief Financial Officer of Omthera Pharmaceuticals, Inc., an emerging specialty pharmaceuticals company until it was purchased by AstrazZeneca Plc. He previously held executive level positions at NRG Energy, serving as Executive Vice President and Chief Financial Officer, and as Senior Vice President Administration and Chief Financial Officer at Medarex Inc., until it was acquired by Bristol-Myers Squibb Co. He also held various corporate finance and capital markets positions in New York and London for both Merrill Lynch and JP Morgan Chase & Co. Mr. Schade currently serves on the Board of Directors of Integra Life Sciences (NASDAQ: IART) where he chairs the Finance Committee, and on the Board of Directors of Sapience Therapeutics, a privately held company. He received an A.B. degree from Princeton University, and an M.B.A. from the Wharton School at the University of Pennsylvania.
This person is not in the org chart
This person is not in any teams